Clinical uses of gene transfer to bone marrow transplants require the establishment of a reproducible method for infecting large numbers of very primitive hematopoietic cells at high efficiency using cell-free retrovirus-containing media. In this study we report the results of experiments with preparations of a high-titer (2-5 X 107/ml) helper-free recombinant neor retrovirus that indicate this goal can now be achieved based on measurements of gene transfer efficiencies to cells referred to as long-term culture initiating cells (LTC-IC) because they give rise to clonogenic cells after 2 5 wk in long-term culture (LTC). Intermittent, repeated exposure of normal human marrow mononuclear cells to virus-containing supernatant over a 3-d period of cell maintenance on an IL-3/granulocyte colonystimulating factor (G-CSF) producing stromal layer resulted in gene transfer efficiencies to LTC-IC of 41%; a level previously obtainable only using co-cultivation infection techniques. Marrow-cells enriched 2 500-fold for LTC-IC (1-2% pure) by flow cytometry showed gene transfer efficiencies of 27% when infected in a similar fashion over a shorter period (24 h), but in the presence of added soluble IL-3 and G-CSF without stromal feeders, and this increased to 61% when Steel factor was also present during the infection period. By using a less highly enriched population of LTC-IC obtained by a bulk immunoselection technique applicable to large-scale clinical marrow harvests, gene transfer efficiencies to LTC-IC of 40% were achieved and this was increased to 60% by short-term preselection in G418. Southern analysis of DNA from the nonadherent cells produced by these LTC over a 6-wk period provided evidence of clonal evolution of LTC-IC in vitro. Leukemic chronic myelogenous leukemia LTC-IC were also infected at high efficiency using the same supernatant infection strategy with growth factor supplementation. These data demonstrate the feasibility ofusing cell-free virus preparations for infecting clinical marrow samples suitable for transplantation, as well as for furAddress reprint requests to Dr. Humphries,
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Introduction
Gene transfer is now widely recognized as a powerful tool for analysis of biological events and disease processes at both the cellular and molecular level. More recently the potential use of gene transfer technology for therapeutic applications has also received considerable attention. Retrovirally mediated gene transfer to human lymphocytes has recently been tested in clinical trials aimed at treating patients with genetic disease (adenosine deaminase deficiency; see reference 1) ,and protocols have been approved to use retroviral marking of bone marrow cells in the context of autologous bone marrow transplantation for malignant disease. In the latter instance, it is hoped that this approach will provide new information concerning the dynamics of marrow recovery and the origin ofcells contributing to relapse. Although a variety of cell types may serve as useful targets for gene transfer in the clinical setting, extensive experience with bone marrow transplantation and progress in isolating and defining the cells likely to be responsible for permanent reconstitution ofthe hematopoietic system have focused interest on primitive hematopoietic cell targets.
Numerous studies documenting retroviral mediated gene transfer to murine bone marrow cells with long-term repopulating ability have now been reported (2-6). Such studies have contributed to a better understanding ofthe proliferative capacity of individual repopulating cells (7) and of the clonal dynamics of repopulation (8, 9) , although reproducible, persistent expression ofthe transferred gene at desired levels remains a matter of concern (10, 1 1) . Results with larger animals such as dogs (12) (13) (14) (15) , sheep (16) , and nonhuman primates (17, 18) have been less impressive, although efficient gene transfer to hematopoietic colony-forming progenitors in these species has been obtained. Gene transfer to human hematopoietic colonyforming progenitors using retroviral vectors has also been reported by a number of groups (19) (20) (21) (22) (23) (24) (25) (26) (27) . Exposure of the target cells to growth factors during the infection period has emerged as an important factor in both murine and human studies (21, 24, 28, 29) and, by using an infection protocol incorporating growth factor stimulation, we have recently shown that high gene transfer efficiency to a more primitive human cell type that gives rise to clonogenic progenitors after 2 5 wk in longterm culture (LTC)' can also be achieved (24) . Similarly, Dick et al. (25) have demonstrated that retrovirally marked human progenitors can be detected for many weeks after transplantation of infected human marrow into immunodeficient mice. Such evidence strongly suggests that hematopoietic cells able to regenerate blood cell formation in bone marrow transplant recipients can be transduced by retroviral vectors.
Efforts to optimize gene transfer efficiencies have concentrated primarily on infection strategies involving co-cultivation of the hematopoietic target cells with virus-producing cells. However, the advantages of this approach may be offset by a diminished recovery of the most primitive cells which are, themselves, adherent (6, 30, 31) . Moreover, the risk of viral producer cells contaminating the target cells renders such methods unsuitable for clinical applications. The present studies were undertaken to determine whether procedures could be devised that would retain high gene transfer efficiency to very primitive human hematopoietic cells (both normal and leukemic) following their exposure to cell-free medium conditioned by virus producer cells. Given the practical advantages of reduced volume exposures and/or increased virus to cell ratios obtainable with purified precursor populations, gene transfer to variably enriched suspensions ofCD34' cells was also evaluated.
Methods
Cell lines. The amphotropic retroviral packaging cell line GP-AM12 and the ecotropic packaging line GP-E86 (32) were used for generation of helper-free recombinant virus. Both lines were cultured in HXM medium, which is a Dulbecco's modified Eagle's medium (DME; Terry Fox Laboratory Media Preparation Service, Vancouver, BC), supplemented with 10% heat-inactivated (550C for 30 min) newborn calf serum (Gibco-BRL, Burlington, Ontario), hypoxanthine (15 CD34' cells were selected by labeling first with anti-CD34/anti-dextran tetrameric complexes, and then with magnetic dextran particles (38, 39) . The separation was carried out by passing the cells over a high-gradient magnetic filter (38, 40) . The resultant population contained 71±6% (mean±SD) CD34' cells.
Target cell infection using producer cell-conditioned medium. Medium conditioned by virus-producer cells was obtained by replacing the medium on near confluent dishes of virus-producer cells, 24 h before planned infections, with DME plus 10% newborn calf serum.
This medium was removed at the time ofinfection and filtered through a 0.22-,gm low-protein binding filter (Millex-GV, Millipore Corp., Bedford, MA), and the target hematopoietic cells were resuspended in this conditioned medium to which 4 ,g/ml polybrene was also added. The cells were then incubated for 2 h at 370C, then centrifuged, and resuspended in LTC medium (see below). Three repeat cycles of this 2-h infection protocol were carried out either over a 24-h period for sorted cells, or once each day for 3 d for other types of target cells. After the infection procedure was finished, an aliquot was removed for clonogenic assays and the remainder used to initiate LTC as described below.
Various growth factors were used to supplement both the viruscontaining medium and the LTC medium in which the cells were incubated during and between each infection. Human granulocyte colonystimulating factor (G-CSF) and interleukin 3 (IL-3) were derived from partially purified conditioned media from Cos cells that had been transfected in our laboratory with the corresponding cDNAs. These were used at a final concentration of 20 ng/ml each. Human stem cell factor (SCF or Steel factor; 41, 42) was obtained from Amgen, Inc. (Thousand Oaks, CA) and used at 100 ng/ml.
Clonogenic progenitor assays. Methylcellulose culture assays were performed as previously described (43) . Granulocyte/macrophage colony-forming unit (GM-CFU) colonies were scored after 10-14 d of incubation, and large erythroid burst-forming unit (BFU-E) colonies (from primitive BFU-E) were counted in the same cultures after 18-21 d using established criteria (43) . In all experiments, control cells were subjected to the same manipulations (with fresh medium replacing the virus-containing conditioned medium) and then plated with or without G418 at the same time as the infected cells. G418 was used at a final concentration of 1.6-1.8 mg/ml (depending on the lot ofG418), which produced no colony growth from uninfected cells. The neor transfer efficiency was calculated as the number of G418-resistant colonies observed divided by the number of colonies obtained without G418, expressed as a percentage.
LTC-IC assays. In general these were carried out as previously described (44, 45) . Normal marrow cells were seeded onto a near-confluent irradiated layer (in 60-mm dishes) of murine M2-10B4 cells half of which had been engineered to produce human G-CSF and the other half human IL-3 (45, 46) . Under these conditions these feeders maintain growth factor concentrations of9 ng/ml for IL-3 and > 140 ng/ml for G-CSF. Input cell numbers varied from 8 to 12 x 106 for light-density normal marrow cells, 1O0 for highly purified cells, 5 X I0O for CD34+ cells, and 5 x 106 for light density CML peripheral blood cells. LTC were then maintained at 33°C in a slightly modified alpha medium containing 12 .5% fetal calf serum, 12.5% horse serum, 10-6 M hydrocortisone sodium hemisuccinate, and 10-4 M 2-mercaptoethanol with weekly half-medium changes and removal of half of the nonadherent (NA) cells. After 5 or 6 wk the NA cells were removed and the adherent layer was trypsinized (47) . Both fractions were assayed for total and neol-resistant BFU-E and CFU-GM. The total number of these progenitors assayed at this time is a measure of the number of LTC-IC in the original inoculum (37).
All manipulations involving amphotropic viruses were performed under level 3 containment following Medical Research Council of Canada guidelines.
Molecular analyses. To demonstrate the presence of a transferred neor gene, individual colonies from methylcellulose dishes that had not been selected with G418 were analyzed using the polymerase chain reaction (PCR; 48). Single colonies were plucked using drawn out capillary pipettes in a minimum (-1 Al) of methylcellulose, then placed in a 50-id lysis buffer (sucrose 0.32 M, Tris-HCI pH 7.5 10 mM, MgCI2 5 mM, 1% Triton X-100). Proteinase K was added (1 ,l of a 10 mg/ml solution), and the sample was incubated for 1 h at 50'C, followed by 10 min at 950C. A fraction (30 sl) was analyzed in a PCR containing buffer (KCl 50 mM, Tris-HCl pH 8.0 10 mM, MgCI2 5 mM), oligomers (1 Armol each), dNTPs (200 mM each), and Taq polymerase (2 U, Gibco-BRL). The reaction was carried out for 30 cycles as previously described (24) , and then Southern blotting was performed using standard techniques (49) . The oligomers used were Neo-L 5'-CAAGATG-GATTGCACGCAGG-3' and Neo-R Y-CTTGACAAGCGGTCC-GAGTT-5'. NA cells from 2-, 4-, and 6-wk-old LTC initiated with CD34+ cells were also analyzed for the presence of the neor gene by conventional Southern blotting (49) . In these experiments, GM-CSF (20 ng/ml) was added to the culture medium (every 2 d) during the last 2 wk ofLTC (weeks 4-6) to enhance NA cell output (45 
Results
An initial series of experiments were conducted to test the efficiency ofgene transfer that could be obtained by using filtered cell-free supernatants containing a high-titer JZen-neo virus to infect low density normal human marrow cells under improved conditions of growth factor stimulation. The choice of growth factors used in this study was based on earlier results with virus producer co-cultivation infection protocols which showed that the addition of G-CSF and IL-3 was the most effective including a comparison to the previous reported combination of GM-CSF, IL-lI#, and human leukocyte conditioned medium (data not shown; 24 much as this would be unlikely to be a clinically practical procedure. Also, to increase the virus to target cell ratio and to allow a better definition of growth factor effects on transfer efficiencies, we used as target cells a subpopulation of CD34++ normal marrow cells that is highly enriched for LTC-IC (37) and depleted of stromal and mature hematopoietic cells. Small numbers of these purified cells (104 per infection condition)
were infected over a period of 24 h by three repeat cycles of exposure to high-titer, filtered, virus-containing supernatants (1 ml/104 cells) for 2 h followed by resuspension and incubation for 6 h in LTC medium. Cells were maintained throughout this period (including exposure to virus) under three different conditions: no added growth factors, IL-3 plus G-CSF, or IL-3 plus G-CSF plus Steel factor. At the end of the 24 h, LTC-IC were assayed by seeding the cells onto M2-1OB4 feeders producing IL-3 plus G-CSF (45 Table I ). Individual colonies grown without G418 selection were plucked and PCR amplification of a 500-bp neor specific fragment was carried out. Southern blot analysis of PCR products from 10 colonies analyzed for each infection condition are shown for a representative experiment. Table I ), suggesting that with this vector, satisfactory levels of neor expression to overcome G418 toxicity are usually achieved. Bulkpurified cells. A next series ofexperiments were undertaken to determine if high-efficiency gene transfer using a supernatant infection technique could be obtained with a population of CD34' cells obtainable using a procedure with the potential for application to large-scale clinical marrow harvests (see Methods). In addition, this procedure provided larger numbers ofcells thus allowing preselection in G418 to be evaluated as a potential manipulation together with more detailed molecular analyses. Analogous to the procedure used for highly purified CD34' cells, bulk-purified cells (71% CD34+) were infected by three repeat cycles of a 2-h exposure to filtered viruscontaining supernatants and then resuspension in LTC medium. In this case infections were performed at daily intervals for 3 d under two conditions: no growth factor supplementation or continuous exposure (including incubation with viral supernatant) to IL-3, G-CSF, and Steel factor. Cells were then maintained in suspension culture for an additional 48 h after infection prior to initiation of LTC either with or without added G418 (1.8 mg/ml). As shown in Fig. 3 , high-efficiency gene transfer to clonogenic and LTC-IC was also achieved in these experiments. For both target cell types, efficiencies of 40% were obtained when infections were accompanied by growth factor stimulation (significantly higher than efficiencies in the absence ofgrowth factors P < 0.02) and this was further increased in each case by a 48-h preselection step (P = 0.1). Absolute recovery of G418-resistant LTC-IC was not affected by preselection indicating no nonspecific toxicity ofthis procedure. (After infection in the presence of growth factor, G418-resistant LTC-IC/total LTC-IC per culture were 1,448±105/ 3,474+72 without preselection, and 1,444±14/2,483±217 with preselection.) NA cells from these LTC were further analyzed by Southern blot to confirm the presence of the transferred neor gene and to assess the clonal derivation of marked cells. Fig. 4 presents results from one such analysis performed on NA cells recovered at 2, 4, and 6 wk after initiation of the LTC. Digestion with XbaI and hybridization to a probe for neor revealed the expected 3.0-kb proviral band at all times tested in cultures that were initiated with cells infected under growth factorstimulated conditions. In contrast, the neor sequence was not detectable by Southern analysis ofNA cells from LTC initiated with cells infected in the absence ofgrowth factors. Digestion of DNA with HindIII to release unique viral integration fragments did not reveal any marked clones in LTC initiated without preselection, whereas one or two unique bands were readily evident in cultures initiated with infected cells that had undergone a preselection step. The difference in intensities ofthe two unique bands detectable at 4 and 6 wk are suggestive of two marked clones. Comparison of the intensity of these bands with that seen in XbaI digested DNA further suggests that by 4 wk, these two clones had become predominant in the NA neoTpositive fraction of this LTC. In contrast, at 2 wk the same clone appears to account for only a minority of the neor-positive population consistent with the presence of many marked clones not detectable as discrete bands. Similar findings of early polyclonal contributions with subsequent emergence of an oligoclonal pattern were obtained in a separate experiment (data not shown).
Leukemic cell targets. For many experimental and potential clinical applications it will be desirable to achieve gene transfer to primitive leukemic stem cells. Recent studies have revealed that in addition to normal LTC-IC a Ph'-positive (leukemic) functional equivalent can also be detected in cells from patients with CML (52) . Peripheral blood mononuclear cells from patients with CML with high leukocyte counts provide a highly enriched source of such leukemic LTC-IC essentially free of normal LTC-IC (53). Therefore, to determine if the methods for gene transfer developed above for normal cells could also be applied to analogous primitive CML cells, peripheral blood mononuclear cells from CML patients with elevated leukocyte counts were subjected to repeated (X3) supernatant infections as in the previous experiments and then seeded onto M2-I OB4 feeders producing IL-3 and G-CSF for LTC-IC assay. Gene transfer efficiencies, both to clonogenic progenitors and LTC-IC, of -35% were observed (Table II) . As with normal The LTC-IC assay allows detection of the most primitive human progenitor that can currently be identified in vitro. However, the relationship ofthese cells to those with short and long-term marrow repopulating ability is not yet established. The ability to both highly purify and efficiently mark LTC-IC now makes the identification and tracking of their progeny in vivo a practical possibility. Our demonstration of retroviral marking of progenitors with sufficient proliferative capacity to dominate the LTC system after 4-6 wk in culture indicates that further investigation of LTC-IC dynamics in vitro using this approach is also possible. By such combined in vitro studies and assessment ofclinical transplants, it should therefore soon be possible to define the functional potential of cells now measured by quantitative in vitro procedures.
